{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:38:33Z","timestamp":1784864313717,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bcp.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T21:30:02Z","timestamp":1485293402000},"page":"73-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Safer topical treatment for inflammation using 5\u03b1-tetrahydrocorticosterone in mouse models"],"prefix":"10.1016","volume":"129","author":[{"given":"Annalisa","family":"Gastaldello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn E.W.","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber J.","family":"Abernethie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.F.","family":"Hadoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.bcp.2017.01.008_b0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2017.01.008_b0010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2017.01.008_b0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","article-title":"The epidemiology of glucocorticoid-associated adverse events","volume":"20","author":"McDonough","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2017.01.008_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2017.01.008_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0030","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1476-5381.2009.00238.x","article-title":"Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases","volume":"158","author":"Schacke","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2017.01.008_b0035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1476-5381.2011.01465.x","article-title":"5alpha-Reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects","volume":"164","author":"Yang","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2017.01.008_b0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01967298","article-title":"Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents","volume":"26","author":"De Young","year":"1989","journal-title":"Agents Actions"},{"key":"10.1016\/j.bcp.2017.01.008_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/neq026","article-title":"Analysis of the potential topical anti-inflammatory activity of Averrhoa carambola L. in mice","volume":"2011","author":"Cabrini","year":"2011","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0039-128X(96)00252-8","article-title":"In vivo and in vitro effects of carbenoxolone on glucocorticoid receptor binding and glucocorticoid activity","volume":"62","author":"Soro","year":"1997","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.bcp.2017.01.008_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/db14-0249","article-title":"5alpha-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents","volume":"64","author":"Livingstone","year":"2015","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.bcp.2017.01.008_b0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-0625.2007.00597.x","article-title":"Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate","volume":"16","author":"Mirshahpanah","year":"2007","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2017.01.008_b0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0300372101","article-title":"Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects","volume":"101","author":"Schacke","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bcp.2017.01.008_b0070","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/me.11.9.1245","article-title":"Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo","volume":"11","author":"Vayssiere","year":"1997","journal-title":"Mol. Endocrinol."},{"issue":"6 Suppl","key":"10.1016\/j.bcp.2017.01.008_b0075","doi-asserted-by":"crossref","first-page":"105S","DOI":"10.1111\/1523-1747.ep12874955","article-title":"The role of keratinocyte cytokines in inflammation and immunity","volume":"95","author":"McKenzie","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcp.2017.01.008_b0080","doi-asserted-by":"crossref","first-page":"916497","DOI":"10.1155\/2013\/916497","article-title":"Cytokines and chemokines in irritant contact dermatitis","volume":"2013","author":"Lee","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"8735","key":"10.1016\/j.bcp.2017.01.008_b0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0140-6736(91)92168-2","article-title":"Keratinocytes as initiators of inflammation","volume":"337","author":"Barker","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/1099-1263(200007\/08)20:4<335::AID-JAT698>3.0.CO;2-L","article-title":"Epidermal cytokines in murine cutaneous irritant responses","volume":"20","author":"Effendy","year":"2000","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/endo-77-4-625","article-title":"A bio-assay for the concomitant assessment of the antiphlogistic and thymolytic activities of topically applied corticoids","volume":"77","author":"Tonelli","year":"1965","journal-title":"Endocrinology"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2017.01.008_b0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01982641","article-title":"The croton oil ear test revisited","volume":"17","author":"Tubaro","year":"1986","journal-title":"Agents Actions"},{"issue":"8","key":"10.1016\/j.bcp.2017.01.008_b0105","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/np200343t","article-title":"Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro","volume":"74","author":"Baumgartner","year":"2011","journal-title":"J. Nat. Prod."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2017.01.008_b0110","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1007\/BF01778311","article-title":"Time-dependent cytokine production in the croton oil-induced mouse ear oedema and inhibition by prednisolone","volume":"44","author":"Towbin","year":"1995","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2017.01.008_b0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.110.168583","volume":"335","author":"Muramoto","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2017.01.008_b0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/exd.12094","article-title":"P2X7 receptor is required for neutrophil accumulation in a mouse model of irritant contact dermatitis","volume":"22","author":"da Silva","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bcp.2017.01.008_b0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.phytochem.2013.09.002","article-title":"Steroids with anti-inflammatory activity from Vernonia nigritiana Oliv. & Hiern","volume":"96","author":"Vassallo","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bcp.2017.01.008_b0130","doi-asserted-by":"crossref","first-page":"301294","DOI":"10.1155\/2014\/301294","article-title":"Cecropia pachystachya: a species with expressive in vivo topical anti-inflammatory and in vitro antioxidant effects","volume":"2014","author":"Pacheco","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.bcp.2017.01.008_b0135","first-page":"51","article-title":"HET-CAM bioassay as in vitro alternative to the croton oil test for investigating steroidal and non-steroidal compounds","volume":"19","author":"Brantner","year":"2002","journal-title":"Altex"},{"issue":"22","key":"10.1016\/j.bcp.2017.01.008_b0140","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.M402822200","article-title":"5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor","volume":"279","author":"McInnes","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2017.01.008_b0145","doi-asserted-by":"crossref","first-page":"22748","DOI":"10.1074\/jbc.M212711200","article-title":"The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism","volume":"278","author":"Kauppi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2017.01.008_b0150","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2174\/156802608784535011","article-title":"Glucocorticoid receptor antagonists","volume":"8","author":"Clark","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2017.01.008_b0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/bj20031022","article-title":"Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter","volume":"378","author":"Ryser","year":"2004","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bcp.2017.01.008_b0160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/jid.2012.373","article-title":"Glutamine suppresses DNFB-induced contact dermatitis by deactivating p38 mitogen-activated protein kinase via induction of MAPK phosphatase-1","volume":"133","author":"Ayush","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"24","key":"10.1016\/j.bcp.2017.01.008_b0165","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1093\/emboj\/20.24.7108","article-title":"Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1","volume":"20","author":"Kassel","year":"2001","journal-title":"EMBO J."},{"issue":"Pt 6","key":"10.1016\/j.bcp.2017.01.008_b0170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1042\/BST0341018","article-title":"Dual-specificity phosphatase 1: a critical regulator of innate immune responses","volume":"34","author":"Abraham","year":"2006","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.bcp.2017.01.008_b0175","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20060336","article-title":"Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1","volume":"203","author":"Abraham","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2017.01.008_b0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2007.04.013","article-title":"Anti-inflammatory functions of glucocorticoid-induced genes","volume":"275","author":"Clark","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0185","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/mol.107.038794","article-title":"Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?","volume":"72","author":"Newton","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"4b","key":"10.1016\/j.bcp.2017.01.008_b0190","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1476-5381.2011.01574.x","article-title":"Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1","volume":"165","author":"Joanny","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2017.01.008_b0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00011-008-7222-7","article-title":"Fluctuation of annexin-A1 positive mast cells in chronic granulomatous inflammation","volume":"57","author":"Oliani","year":"2008","journal-title":"Inflamm. Res."},{"issue":"6","key":"10.1016\/j.bcp.2017.01.008_b0200","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1074\/jbc.M606262200","article-title":"Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation","volume":"282","author":"Stojadinovic","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7193","key":"10.1016\/j.bcp.2017.01.008_b0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2017.01.008_b0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00000658-198709000-00016","article-title":"Angiostatic steroids. Method of discovery and mechanism of action","volume":"206","author":"Folkman","year":"1987","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.bcp.2017.01.008_b0215","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.bjp.0705731","article-title":"Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO)","volume":"141","author":"Ferreira","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"34","key":"10.1016\/j.bcp.2017.01.008_b0220","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0500641102","article-title":"Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis","volume":"102","author":"Small","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2017.01.008_b0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(03)00224-2","article-title":"The unfolding tale of PECAM-1","volume":"540","author":"Jackson","year":"2003","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0230","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","article-title":"The role of pericytes in blood-vessel formation and maintenance","volume":"7","author":"Bergers","year":"2005","journal-title":"Neuro Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2017.01.008_b0235","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.172.7.4410","article-title":"Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response","volume":"172","author":"Sunderkotter","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ncb2926","article-title":"The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis","volume":"16","author":"Bentley","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2017.01.008_b0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1160\/TH12-09-0678","article-title":"Cellular and molecular regulation of vascular permeability","volume":"109","author":"Goddard","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.bcp.2017.01.008_b0250","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI114322","article-title":"Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis","volume":"84","author":"Connolly","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2017.01.008_b0255","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0260","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2017.01.008_b0265","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood-2003-06-1820","article-title":"Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcp.2017.01.008_b0270","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.RES.0000246113.82111.2d","article-title":"Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction","volume":"99","author":"Morimoto","year":"2006","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2017.01.008_b0275","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2133.2002.04949.x","article-title":"Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases","volume":"147","author":"Oishi","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.bcp.2017.01.008_b0280","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1083\/jcb.107.4.1589","article-title":"Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures","volume":"107","author":"Kubota","year":"1988","journal-title":"J. Cell Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2017.01.008_b0285","first-page":"33","article-title":"How do epidermal matrix metalloproteinases support re-epithelialization during skin healing?","volume":"25","author":"Michopoulou","year":"2015","journal-title":"Eur. J. Dermatol."},{"issue":"10","key":"10.1016\/j.bcp.2017.01.008_b0290","doi-asserted-by":"crossref","first-page":"e46625","DOI":"10.1371\/journal.pone.0046625","article-title":"Inhibition of proliferation, migration and proteolysis contribute to corticosterone-mediated inhibition of angiogenesis","volume":"7","author":"Shikatani","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2017.01.008_b0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jsre.2001.6220","article-title":"Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity","volume":"102","author":"Pross","year":"2002","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.bcp.2017.01.008_b0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1780005","article-title":"MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?","volume":"178","author":"Clark","year":"2003","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2017.01.008_b0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(03)00439-3","article-title":"Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38","volume":"546","author":"Clark","year":"2003","journal-title":"FEBS Lett."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217300382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217300382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T18:21:49Z","timestamp":1536085309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217300382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":61,"alternative-id":["S0006295217300382"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.01.008","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safer topical treatment for inflammation using 5\u03b1-tetrahydrocorticosterone in mouse models","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}